Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today highlighted data presented at the American Association ...

A newly proposed model suggests cancer cells may resist treatment not just through genetic mutations, but by dynamically reprogramming their gene activity. Credit: Shutterstock Cancer cells may “learn ...

Phase 1 Dose Escalation Underway at Six Leading U.S. Oncology Centers; MYC Overexpression and CDKN2A/B Deletion Identified as ...

A new nanomedicine strategy enhances irinotecan delivery in pancreatic tumors, reduces resistance, and boosts antitumor ...

A new meeting report was published in Volume 18 of Aging-US on April 6, 2026, titled "Toward actionable interventions in ...

Roswell Park researchers present a two-step, mechanism-based drug strategy at AACR 2026 that selectively targets cancers with ...

Brain organoids reveal that two genetic mutations in DEPDC5 drive epilepsy, disrupting early brain development, and causing ...

Panakeia ("the Company"), the world's first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual ...

AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.

The ventral tegmental area (VTA) is a key site for opioid actions, and emerging evidence suggests that pain states and opioid experience both induce transcriptional, molecular, and circuit adaptations ...

Myalgic encephalomyelitis (ME), long known as chronic fatigue syndrome, is now recognized as a complex, multi-system disease.

Six people have been charged with plotting to steal at least 20 cars from the Washington, D.C., area and sell them to buyers in the United States and Ghana in West Africa, ...